Report on the risk assessment of 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) in the framework of the Council Decision on new psychoactive substances
Series type: Risk assessments
Summary
This publication presents the data and findings of the risk assessment on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 27 September 2018, the Council decided that methoxyacetylfentanyl should be subject to control measures across the Member States.
Table of contents
- Foreword
- EMCDDA actions on monitoring and responding to new drugs
- EMCDDA‒Europol Joint Report on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl): a summary
- Risk Assessment Report of a new psychoactive substance: 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl)
- Annex 1: Technical report on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl)
- Participants of the risk assessment meeting
Council Implementing Decision on subjecting methoxyacetylfentanyl to control measures
Pages:
58
Price:
Free
ISBN:
978-92-9497-344-3
ISSN:
1725-4493
Pub. DOI:
10.2810/520464
Catalog Number:
TDAK18008ENN